Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cardiovascular Research

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvt173PMID 23812417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines.

  2015cited by this paper
• The Framingham Study

  2014cited by this paper
• Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction

  2012influential reference
• MicroRNAs in stress signaling and human disease.

  2012cited by this paper
• MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.

  2012cited by this paper
• MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue.

  2012cited by this paper
• Transforming Growth Factor-β1 (TGF-β1) Utilizes Distinct Pathways for the Transcriptional Activation of MicroRNA 143/145 in Human Coronary Artery Smooth Muscle Cells*

  2011cited by this paper
• PolyA RT-PCR-based quantification of microRNA by using universal TaqMan probe

  2011cited by this paper
• Role of microRNAs in diabetes and its cardiovascular complications

  2011cited by this paper
• Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

  2011influential reference
• Myocardial, Perivascular, and Epicardial Fat

  2011cited by this paper
• Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte function

  2011influential reference
• The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease

  2010cited by this paper
• MicroRNA-21 in Cardiovascular Disease

  2010cited by this paper
• Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes

  2010influential reference
• microRNAs in heart disease: putative novel therapeutic targets?

  2010cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Metabolic toxicity of the heart: insights from molecular imaging.

  2010influential reference
• Identification of non-coding RNAs embracing microRNA-143/145 cluster

  2010cited by this paper
• Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.

  2009cited by this paper
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

  2009cited by this paper
• Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks*

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Targeting microRNAs in obesity

  2009cited by this paper
• miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions

  2009cited by this paper
• Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet.

  2008cited by this paper
• Altered microRNA expression in human heart disease.

  2007cited by this paper
• Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells*

  2007cited by this paper
• Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy

  2007influential reference
• Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

  2002cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• Diabetes and cardiovascular disease

  2000cited by this paper
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte.

  1998cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• New type of cardiomyopathy associated with diabetic glomerulosclerosis.

  1972cited by this paper

• Concomitant Diabetes and Atrial Fibrillation: Epicardial Fat and Macrophage‐Related Mechanisms

  2025cites this paper
• Study of independent diagnostic efficacy and co-diagnostic strategies of molecular markers for diabetic cardiomyopathy

  2025cites this paper
• Diabetic cardiomyopathy: Mechanistic insights on molecular pathways and emerging therapeutic approaches

  2025cites this paper
• The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction

  2025cites this paper
• Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation

  2024cites this paper
• Activins and Inhibins in Cardiovascular Pathophysiology

  2024cites this paper
• Role of epicardial adipose tissue in the pathogenesis of chronic inflammation in heart failure with preserved ejection fraction

  2024cites this paper
• Potential clinical biomarkers and perspectives in diabetic cardiomyopathy

  2023cites this paper
• Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy

  2023cites this paper
• Fat-to-heart crosstalk in health and disease

  2023influential citation
• Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats

  2023cites this paper
• Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease.

  2022cites this paper
• A cellular regulator of the niche: telocyte

  2022cites this paper
• Review: Detection of Subclinical Diabetic cardiomyopathy Before Being Overt Heart Failure

  2022cites this paper
• miR-143-Mediated Responses to Betaine Supplement Repress Lipogenesis and Hepatic Gluconeogenesis by Targeting MAT1a and MAPK11.

  2022cites this paper
• Adipose‐related microRNAs as modulators of the cardiovascular system: the role of epicardial adipose tissue

  2021cites this paper
• Role of novel biomarkers in diabetic cardiomyopathy

  2021cites this paper
• Peripartum cardiomyopathy

  2021cites this paper
• Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation

  2021cites this paper
• ORP5 and ORP8: Sterol Sensors and Phospholipid Transfer Proteins at Membrane Contact Sites?

  2020cites this paper
• Role of Non-coding RNA in Diabetic Cardiomyopathy.

  2020cites this paper
• Transcriptomic and Proteomic Analysis of the Epicardial Adipose Tissue

  2020cites this paper
• Forced expression of miR-143 and -145 in cardiomyocytes induces cardiomyopathy with a reductive redox shift

  2020cites this paper
• Epicardial Adipose Tissue: From Cell to Clinic

  2020cites this paper
• Adrenal Secretome and Epicardial Adipose Tissue

  2020cites this paper
• The role of microRNAs in the healing of diabetic ulcers

  2019cites this paper
• Peripartum cardiomyopathy

  2019cites this paper
• Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches.

  2019cites this paper
• Insight into miRNAs related with glucometabolic disorder.

  2019cites this paper
• Obesity is a common soil for premature cardiac aging and heart diseases - Role of autophagy.

  2019cites this paper
• The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.

  2019cites this paper
• The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: A review

  2019cites this paper
• The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases.

  2019cites this paper
• Analysis of long non-coding RNA and mRNA profiles in epicardial adipose tissue of patients with atrial fibrillation.

  2019cites this paper
• MicroRNA‐145 regulates disabled‐2 and Wnt3a expression in cardiomyocytes under hyperglycaemia

  2018cites this paper
• The role of adipose tissue in cardiovascular health and disease

  2018cites this paper
• Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?

  2018cites this paper
• Single Cell Analysis Identifies the miRNA Expression Profile of a Subpopulation of Muscle Precursor Cells Unique to Humans With Type 2 Diabetes

  2018cites this paper
• A Novel Regulator of Type II Diabetes: MicroRNA-143.

  2018cites this paper
• Bridging the molecular and biological functions of the oxysterol-binding protein family

  2018cites this paper
• The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles

  2017influential citation
• Mechanisms Involved in Premature Aging in the Heart—Is There an Implication for Cardiac Surgery?

  2017cites this paper
• Soluble CD14 inhibits contractile function and insulin action in primary adult rat cardiomyocytes.

  2017cites this paper
• Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.

  2017cites this paper
• Hyperglycemia is associated with reduced testicular function and activin dysregulation in the Ins2Akita+/- mouse model of type 1 diabetes.

  2017cites this paper
• Diagnostic approaches for diabetic cardiomyopathy

  2017cites this paper
• Title TGF-beta Signaling from Receptors to Smads Permalink

  2016cites this paper
• miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.

  2016cites this paper
• Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin–angiotensin system and induction of miR-208a

  2016cites this paper
• Functional similarities between microRNAs inferred from biomedical texts

  2016cites this paper
• TGF-β Signaling from Receptors to Smads.

  2016cites this paper
• New Molecular Insights of Insulin in Diabetic Cardiomyopathy

  2016influential citation
• Regulatory Roles of MicroRNAs in Diabetes

  2016cites this paper
• Hot topics and networks in Cardiovascular Research.

  2015cites this paper
• Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyte

  2015cites this paper
• MicroRNA-143/-145 in Cardiovascular Diseases

  2015cites this paper
• MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGFβI during Skeletal Muscle Development in Pigs

  2015cites this paper
• The vulnerable myocardium. Diabetic cardiomyopathy.

  2015cites this paper
• The Role of MicroRNAs in Diabetic Complications—Special Emphasis on Wound Healing

  2014cites this paper
• Adipocyte-derived factors impair insulin signaling in differentiated human vascular smooth muscle cells via the upregulation of miR-143.

  2014cites this paper
• The vulnerable myocardium

  2014cites this paper
• Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease

  2014cites this paper
• The Role of microRNAs in Cardiovascular Disease

  2012cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper
• International Journal of Molecular Sciences the Role of P38 Mapk in the Development of Diabetic Cardiomyopathy

  year unknowncites this paper